Results 191 to 200 of about 7,359,221 (290)
ABSTRACT Using the full population of letter‐graded organisations in the licensed CDP climate score files from 2016 to 2025 (37,450 firm‐years across 8959 firms), this study examines how CDP‐assessed climate disclosure quality evolves over time.
Alexander Ryota Keeley +3 more
wiley +1 more source
Variation in capability, organisational structure, and treatment processes for critically ill adults with moderate-to-severe traumatic brain injury in Australia and New Zealand. [PDF]
Taylor JD +24 more
europepmc +1 more source
ABSTRACT Fiber‐Textile‐Apparel‐Retail (FTAR) firms communicate their fashion corporate social responsibility (fCSR) efforts to stakeholders to obtain operational legitimacy. However, little is known about the extent to which fCSR disclosures align with stakeholder expectations and sustainability principles.
Hye Seung Jeong, Yoo‐Kyoung Seock
wiley +1 more source
Life-sustaining therapy limitation in critical illness: unequal weights of demographics, disease severity, and comorbidities. [PDF]
Ribeiro GLH +3 more
europepmc +1 more source
ABSTRACT This study examines the institutionalization and textual evolution of sustainability reporting among listed real estate investment trusts (REITs) in the United States, the United Kingdom, Australia, Singapore, and Japan between 2020 and 2025.
Seonghun Min
wiley +1 more source
Continue or discontinue antihypertensive medication in hospitalized patients-The coin has two sides. [PDF]
Bárány P.
europepmc +1 more source
ABSTRACT Objective Expected body weight (EBW) determination is common in eating disorder (ED) treatment, yet no evidence‐based guidelines exist for how to discuss EBWs with patients. Clinicians have previously conceptualized these discussions as therapeutic exposures targeting fear of weight gain.
Agatha A. Laboe +6 more
wiley +1 more source
Response to [Glycated Albumin-Guided Therapy: Biomarker Utility or Earlier Treatment Intensification?]. [PDF]
Ren Q, Ji L.
europepmc +1 more source
ABSTRACT Artificial intelligence (AI) has advanced rapidly in glaucoma, but many models remain optimized for case‐control detection rather than the clinically harder task of distinguishing glaucoma from its mimickers. This narrative review primarily examined literature published from January 2018 to March 2026 on glaucoma AI, difficult comparator ...
Cansu Yüksel Elgin
wiley +1 more source
End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy. [PDF]
Giantin V +11 more
europepmc +1 more source

